Tag:

ABT-450

Latest Headlines

Latest Headlines

10 top drugs in biopharma's late-stage pipeline

In drug development, everything's a gamble, if you're doing something new and shooting at a big target. But there has to be a reasonable assumption that if safety issues aren't being glossed over and the efficacy data hold up, these top drugs can change standards of care and grab market share. So here's my pick of the likely big winners >>

Abbott wows the crowd with promising Phase II hep C data

You can count Abbott as a key player in the hot hepatitis C drug development race.